Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03RYN
|
||||
Former ID |
DNCL003013
|
||||
Drug Name |
Cytolin
|
||||
Drug Type |
Antibody
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Preclinical | [550574] | ||
Company |
CytoDyn
|
||||
Target and Pathway | |||||
Target(s) | Lymphocyte function-associated antigen 1 | Target Info | [528611] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Cell adhesion molecules (CAMs) | |||||
Natural killer cell mediated cytotoxicity | |||||
Leukocyte transendothelial migration | |||||
Regulation of actin cytoskeleton | |||||
Malaria | |||||
Staphylococcus aureus infection | |||||
HTLV-I infection | |||||
Epstein-Barr virus infection | |||||
Rheumatoid arthritis | |||||
Viral myocarditis | |||||
NetPath Pathway | TCR Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
Pathway Interaction Database | Integrin family cell surface interactions | ||||
Beta2 integrin cell surface interactions | |||||
CXCR3-mediated signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.